Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.

1 May 1991

Abstract excerpt

During latent Epstein-Barr virus (EBV) infection of human B lymphocytes, six viral nuclear antigen (EBNAs) are expressed from long primary transcripts by means of alternative splicing and alternative polyadenylylation sites. These transcripts initiate from one of two promoters, Cp or Wp, that function in a mutually exclusive fashion. Wp is exclusively utilized during the initial stages of infection of primary B...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 1850841
DOI: 10.1073/pnas.88.9.3942

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.PMID 1850841Read ↗

Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.Semantic proximity Read ↗

B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.Semantic proximity Read ↗

oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell linesSemantic proximity Read ↗

Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP proteinSemantic proximity Read ↗

Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell TransformationSemantic proximity Read ↗

Molecular genetic analysis of Epstein-Barr virus Cp promoter function.Semantic proximity Read ↗

Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier stateSemantic proximity Read ↗

Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.Semantic proximity Read ↗

A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNASemantic proximity Read ↗

The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulatedSemantic proximity Read ↗

Functional differences between type 1 and type 2 Epstein-Barr virus EBNA-2Semantic proximity Read ↗

Analysis of Epstein-Barr Virus-Regulated Host Gene Expression Changes through Primary B-Cell Outgrowth Reveals Delayed Kinetics of Latent Membrane Protein 1-Mediated NF-κB ActivationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.